Solesence (SLSN) Cash & Equivalents (2010 - 2026)

Solesence (SLSN) has reported Cash & Equivalents for 17 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 74.54% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (down 74.54% YoY), and the FY2025 full-year result was $1.3 million, down 8.59% from the prior year.
• Cash & Equivalents improved to $1.0 million in Q2 2026 per SLSN's latest filing, from $573000.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $4.1 million in Q2 2025 and bottomed at $429000.0 in Q3 2025.
• Historically, Cash & Equivalents has averaged $1.6 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents jumped 232.72% in 2022, then slumped 85.33% in 2025.
• Over 5 years, Cash & Equivalents stood at $2.2 million in 2022, then retreated by 21.23% to $1.7 million in 2023, then slipped by 18.18% to $1.4 million in 2024, then dropped by 8.59% to $1.3 million in 2025, then fell by 18.79% to $1.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $1.0 million, $573000.0, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.